RECURRENT ORAL CAVITY CARCINOMA

Clinical trials for RECURRENT ORAL CAVITY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ORAL CAVITY CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT ORAL CAVITY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Pill combo aims to tame recurrent head and neck cancer in rural patients

Disease control Recruiting now

This study tests whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for people with head and neck cancer that has come back or spread. The trial enrolls 25 adults in the rural Midwest and uses virtual visits to reduce travel bu…

Matched conditions: RECURRENT ORAL CAVITY CARCINOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 15, 2026 10:42 UTC

RECURRENT ORAL CAVITY CARCINOMA

Get alerted when new RECURRENT ORAL CAVITY CARCINOMA trials appear

Pill combo aims to tame recurrent head and neck cancer in rural patients